Glenmark USA launches Lacosamide Oral Solution, 10 mg/mL
According to IQVIATM sales data for the 12-month period ending October 2024, the Vimpat Oral Solution, 10 mg/mL market achieved annual sales of approximately $57.0 million
According to IQVIATM sales data for the 12-month period ending October 2024, the Vimpat Oral Solution, 10 mg/mL market achieved annual sales of approximately $57.0 million
Final decision from the European Commission is anticipated within the coming months
Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC) is used to temporarily relieve itchy eyes due to pollen, ragweed, grass, animal hair and dander
Glenmark's Travoprost Ophthalmic Solution USP, 0.004% is bioequivalent and therapeutically equivalent to the reference listed drug, Travatan Z Ophthalmic Solution USP, 0.004% of Sandoz
The product will be marketed by Dr. Reddy's
Granules now has a total of 67 ANDA approvals from the USFDA
Prednisolone Acetate Ophthalmic Suspension is the first generic version of Pred Forte
Cetirizine is used for relief of symptoms of hay fever and other allergic conditions
HSGP is engaged closely with the USFDA and is committed to address the OAI observations through planned remediation measures
Paliperidone extended-release tablets are an atypical antipsychotic agent indicated for treatment of schizophrenia
Subscribe To Our Newsletter & Stay Updated